Hakim Bouterfa
Amministratore Delegato presso PentixaPharm GmbH
Profilo
Hakim Larbi Bouterfa is the founder of OctreoPharm Sciences GmbH, which was founded in 2009.
Dr. Bouterfa is also the founder of PentixaPharm GmbH.
He is currently the Managing Partner at 1717 Life Sciences Ventures GmbH since 2017.
In the past, Dr. Bouterfa worked as the Medical Director-Sandostatin Franchise at Novartis Pharma GmbH and as the Managing Director & VP-European Operations at Molecular Insight Pharmaceuticals GmbH.
He also served as the Chief Medical Officer at Eckert & Ziegler SE in 2023.
Posizioni attive di Hakim Bouterfa
| Società | Posizione | Inizio |
|---|---|---|
| 1717 Life Sciences Ventures GmbH | Investitore di Private Equity | 01/01/2017 |
PentixaPharm GmbH
 PentixaPharm GmbH BiotechnologyHealth Technology Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Amministratore Delegato | - |
Precedenti posizioni note di Hakim Bouterfa
| Società | Posizione | Fine |
|---|---|---|
| ECKERT & ZIEGLER SE | Direttore Tecnico/Scientifico/R&S | 31/12/2023 |
Molecular Insight Pharmaceuticals GmbH
 Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of Lantheus Holdings, Inc., Molecular Insight Pharmaceuticals GmbH develops and commercializes innovative molecular imaging pharmaceuticals. The company is based in Wuerzburg, Germany. | Amministratore Delegato | - |
Novartis Pharma GmbH
 Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Aziende private | 5 |
|---|---|
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Health Technology |
Molecular Insight Pharmaceuticals GmbH
Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of Lantheus Holdings, Inc., Molecular Insight Pharmaceuticals GmbH develops and commercializes innovative molecular imaging pharmaceuticals. The company is based in Wuerzburg, Germany. | Health Technology |
| 1717 Life Sciences Ventures GmbH | Finance |
PentixaPharm GmbH
PentixaPharm GmbH BiotechnologyHealth Technology Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Health Technology |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Health Technology |
- Borsa valori
- Insiders
- Hakim Bouterfa
